Avalon Pharma’s Profits Soar 21% – Is This the Pharma Stock to Watch in 2025?
Avalon Pharma has wrapped up a successful financial year, reporting a 21% jump in net profit for 2024. The impressive growth comes as the company continues to expand its market presence, optimize operations, and capitalize on rising demand for pharmaceutical products. Strong Sales Drive Profit Growth The pharmaceutical giant saw steady revenue growth throughout the…